)
Novanta (NOVT) investor relations material
Novanta 46th Annual William Blair Growth Stock Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Strategic direction and market focus
Shifted portfolio from 10% to over 50% exposure in medical end markets, reducing cyclicality and increasing recurring revenue streams.
Reduced semiconductor exposure from nearly 50% to 10–15%, while increasing robotics and automation to about 20% of advanced industrial sales.
Medical consumables now represent 15% of the portfolio, up from 0% eight years ago, growing at double digits.
Intelligent subsystems, combining hardware and embedded software, now account for 30% of business, up from less than 5% a decade ago.
Focused on high-growth, secular markets such as minimally invasive surgery, robotic surgery, precision medicine, and advanced industrial automation.
Innovation and technology leadership
Provides mission-critical, proprietary technologies that are typically sole-sourced for the lifetime of customer equipment.
Leading in end-of-arm technologies for surgical robotics, including sensing, motion control, and haptic feedback.
Developed unique safety and sensing solutions for advanced robotics, including technology for safe robot failure and human-robot interaction.
Supplies advanced laser and light manipulation subsystems for applications like 3D printing, EUV lithography, and GPU chip testing.
Integrates light and motion expertise for precision medicine and life sciences, supporting high-throughput, accurate diagnostics.
Growth platforms and financial model
Five key growth platforms: insufflation and fluid management, robotic surgery, advanced robotics, light manipulation, and precision medicine.
About 15% of sales are linked to GenAI infrastructure, growing 20% last quarter, with further acceleration expected.
Insufflation and fluid management business expected to double from $200M in 2024 to $400M by 2030.
Medical consumables business now $150M, growing strong double digits, and not tied to capital investment cycles.
M&A strategy has deployed over $1.2B across 20+ acquisitions, compounding growth and expanding technology offerings.
- Directors, executive pay, and auditor were approved; no shareholder questions were raised.NOVT
AGM 20263 Jun 2026 - Q1 2026 revenue up 10.4%, bookings up 37%, and cash flow surged, with strong 2026 outlook.NOVT
Q1 202612 May 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.NOVT
Proxy filing24 Apr 2026 - Record revenue, strong bookings, and 2026 guidance project further growth and margin expansion.NOVT
Q4 202510 Apr 2026 - Q2 revenue up 2.8% to $236M, with medical growth offsetting weak industrial demand.NOVT
Q2 20242 Feb 2026 - Q3 2024 revenue up 10.3% to $244.4M, with acquisitions driving growth and flat organic sales.NOVT
Q3 202416 Jan 2026 - 2024 saw record cash flow, margin gains, and new products; 2025 targets 5% growth amid volatility.NOVT
Q4 202411 Dec 2025 - Annual meeting covers director elections, say-on-pay, auditor appointment, and ESG oversight.NOVT
Proxy Filing1 Dec 2025 - Q1 2025 delivered revenue growth, higher net income, and resilient guidance amid trade risks.NOVT
Q1 202528 Nov 2025
Next Novanta earnings date
Next Novanta earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage